1
|
Castells-Sala C, Pérez ML, Agustí E, Aiti A, Tarragona E, Navarro A, Tabera J, Fariñas O, Pomar JL, Vilarrodona A. Last twenty-years activity of cardiovascular tissue banking in Barcelona. Cell Tissue Bank 2024; 25:11-26. [PMID: 36849631 PMCID: PMC9970124 DOI: 10.1007/s10561-022-10059-9] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/27/2022] [Accepted: 12/04/2022] [Indexed: 03/01/2023]
Abstract
The Barcelona Tissue Bank was established from the merge of two previous multi-tissue banks. Potential donors are screened by Donor Center staff and multi-tissue retrieval is performed by specialized own teams. Tissue processing and preservation is performed in clean room facilities by specialised personnel. After quality control of both donor and all tissues results, the heart valves and vascular segments are stored until medical request. The aim of this report is to present the cardiovascular tissue activity and retrospectively evaluate the outcomes of the changes performed in last 20 years. Cardiovascular tissue from 4088 donors was received, specifically 3115 hearts and 2095 vascular segments were processed and evaluated. A total of 48% of the aortic valves, 68% of the pulmonary valves and 75% of the vascular segments were suitable for transplant. The main reason for discarding tissue was macroscopic morphology followed by microbiological results, for both valves and arteries. Altogether, 4360 tissues were distributed for transplantation: 2032 (47%) vascular segments, 1545 (35%) pulmonary valves and 781 (18%) aortic valves. The most common indication for aortic valve surgery was the treatment of endocarditis, while for pulmonary valves, it was congenital malformation reconstruction. Vascular segments were mainly used for reconstruction after ischemia. During this period, a number of changes were made with the goal of enhancing tissue quality, safety and efficacy. These improvements were achieved through the use of a new antibiotic cocktail, increasing of donor age criteria and changing the microbiological control strategy.
Collapse
Affiliation(s)
- C. Castells-Sala
- Barcelona Tissue Bank, Banc de Sang i Teixits (BST), Barcelona, Spain
- Biomedical Research Institute (IIB-Sant Pau; SGR1113), Barcelona, Spain
- Barcelona Tissue Bank (BTB), Banc de Sang i Teixits (BST, GenCAT) Passeig Taulat 116, E-08005 Barcelona, Spain
| | - M. L. Pérez
- Barcelona Tissue Bank, Banc de Sang i Teixits (BST), Barcelona, Spain
- Vall Hebron Institute of Research (VHIR), Barcelona, Spain
| | - E. Agustí
- Barcelona Tissue Bank, Banc de Sang i Teixits (BST), Barcelona, Spain
- Vall Hebron Institute of Research (VHIR), Barcelona, Spain
| | - A. Aiti
- Barcelona Tissue Bank, Banc de Sang i Teixits (BST), Barcelona, Spain
| | - E. Tarragona
- Barcelona Tissue Bank, Banc de Sang i Teixits (BST), Barcelona, Spain
| | - A. Navarro
- Organització Catalana de Trasplantaments (OCATT), Barcelona, Spain
| | - J. Tabera
- Barcelona Tissue Bank, Banc de Sang i Teixits (BST), Barcelona, Spain
- Biomedical Research Institute (IIB-Sant Pau; SGR1113), Barcelona, Spain
| | - O. Fariñas
- Barcelona Tissue Bank, Banc de Sang i Teixits (BST), Barcelona, Spain
- Biomedical Research Institute (IIB-Sant Pau; SGR1113), Barcelona, Spain
| | - J. L. Pomar
- Institute for Cardiovascular Diseases. Hospital Clinic de Barcelona, University of Barcelona, Barcelona, Spain
| | - A. Vilarrodona
- Barcelona Tissue Bank, Banc de Sang i Teixits (BST), Barcelona, Spain
- Vall Hebron Institute of Research (VHIR), Barcelona, Spain
| |
Collapse
|
2
|
Axelsson I, Gustafsson A, Isaksson H, Nilsson J, Malm T. Impact of storage time prior to cryopreservation on mechanical properties of aortic homografts. Cell Tissue Bank 2024; 25:27-37. [PMID: 36843158 PMCID: PMC10902001 DOI: 10.1007/s10561-023-10079-z] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/07/2022] [Accepted: 02/04/2023] [Indexed: 02/28/2023]
Abstract
Optimal time spans in homograft procurement are still debatable among tissue banks and needs to be further investigated. Cell viability decreases at longer preparation intervals, but the effect on collagen and elastic fibers has not been investigated to the same extent. These fibers are of importance to the homograft elasticity and strength. The objective of this study was to analyze the mechanical properties of homograft tissue at different time spans in the procurement process. Ten aortic homografts were collected at the Tissue Bank in Lund. Twelve samples were obtained from each homograft, cryopreserved in groups of three after 2-4 days, 7-9 days, 28-30 days, and 60-62 days in antibiotic decontamination. Mechanical testing was performed with uniaxial tensile tests, calculating elastic modulus, yield stress and energy at yield stress. Two randomly selected samples were assessed with light microscopy. Procurement generated a total of 120 samples, with 30 samples in each time group. Elastic modulus and yield stress was significantly higher in samples cryopreserved after 2-4 days (2.7 MPa (2.5-5.0) and 0.78 MPa (0.68-1.0)) compared to 7-9 days (2.2 MPa (2.0-2.6) and 0.53 MPa (0.46-0.69)), p = 0.008 and 0.011 respectively. Light microscopy did not show any difference in collagen and elastin at different time spans. There was a significant decrease in elastic modulus and yield stress after 7 days of decontamination at 4 °C compared to 2-4 days. This could indicate some deterioration of elastin and collagen at longer decontamination intervals. Clinical significance of these findings remains to be clarified.
Collapse
Affiliation(s)
- Ida Axelsson
- Tissue Bank Lund, Baravägen 37, 22242, Lund, Sweden.
- Department of Cardiothoracic Surgery, Skane University Hospital, Lund, Sweden.
- Department of Clinical Science, Cardiothoracic Surgery, Lund University, Lund, Sweden.
| | - Anna Gustafsson
- Department of Biomedical Engineering, Lund University, Lund, Sweden
| | - Hanna Isaksson
- Department of Biomedical Engineering, Lund University, Lund, Sweden
| | - Johan Nilsson
- Department of Cardiothoracic Surgery, Skane University Hospital, Lund, Sweden
- Department of Clinical Science, Cardiothoracic Surgery, Lund University, Lund, Sweden
- Department of Translational Medicine, Artificial Intelligence and Bioinformatics in Cardiothoracic Sciences, Lund University, Lund, Sweden
| | - Torsten Malm
- Tissue Bank Lund, Baravägen 37, 22242, Lund, Sweden
- Department of Clinical Science, Cardiothoracic Surgery, Lund University, Lund, Sweden
- Pediatric Cardiac Surgery Unit, Children's Hospital, Skane University Hospital, Lund, Sweden
| |
Collapse
|
3
|
Axelsson I, Malm T, Nilsson J. Does microbiological contamination of homografts prior to decontamination affect the outcome after right ventricular outflow tract reconstruction? Interact Cardiovasc Thorac Surg 2021; 33:605-613. [PMID: 34000042 DOI: 10.1093/icvts/ivab126] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 12/09/2020] [Revised: 02/08/2021] [Accepted: 03/10/2021] [Indexed: 11/13/2022] Open
Abstract
OBJECTIVES Homografts are often in short supply. Today, European guidelines recommend that all tissues contaminated by any of 18 different bacteria and fungi be discarded before antibiotic decontamination has been conducted. The tissue bank in Lund uses more liberal protocols: It accepts all microbes prior to decontamination except multiresistant microbes and Pseudomonas species. The aim of this study was to analyse the effect of contamination on the long-term outcome and occurrence of endocarditis in recipients. METHODS Data were collected on homografts and on recipients of homografts in the right ventricular (RV) outflow tract who were operated on between 1995 and 2018 in Lund. The long-term outcome of recipients was analysed in relation to different types of contamination using Cox proportional hazard regression. The proportion of patients with endocarditis was analysed with the χ2 test. RESULTS The study included 509 implanted homografts. Follow-up was a maximum of 24 years and 99% complete. A total of 156 (31%) homografts were contaminated prior to antibiotic decontamination. Homografts contaminated with low-risk microbes had the lowest reintervention rate, but there was no significant difference compared to no contamination [hazard ratio (HR) 1.1, 95% confidence interval (CI) 0.73-1.7] or contamination with high-risk microbes (HR 1.6, 95% CI 0.87-2.8) in the multivariable analysis. There was no significant difference in the proportion of cases of endocarditis during the follow-up period between recipients of homografts contaminated prior to decontamination and recipients of homografts with no contamination (P = 0.83). CONCLUSIONS Contamination of homograft tissue prior to decontamination did not show any significant effect on the long-term outcome or the occurrence of endocarditis after implantation in the RV outflow tract. Most contaminated homografts can be used safely after approved decontamination.
Collapse
Affiliation(s)
- Ida Axelsson
- Tissue Bank Lund, Lund University, Skane University Hospital, Lund, Sweden.,Department of Clinical Science Lund, Cardiothoracic Surgery, Lund University, Skane University Hospital, Lund, Sweden
| | - Torsten Malm
- Tissue Bank Lund, Lund University, Skane University Hospital, Lund, Sweden.,Pediatric Cardiac Surgery Unit, Children's Hospital, Lund University, Skane University Hospital, Lund, Sweden
| | - Johan Nilsson
- Department of Clinical Science Lund, Cardiothoracic Surgery, Lund University, Skane University Hospital, Lund, Sweden
| |
Collapse
|
4
|
Georges G, Allard B, Dakkak M, Nourissat G, Febrer G. Appraising 5 years in activity of the largest public Canadian vascular graft bank. J Vasc Surg 2021; 74:972-978. [PMID: 33684476 DOI: 10.1016/j.jvs.2021.02.022] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 09/03/2020] [Accepted: 02/08/2021] [Indexed: 11/17/2022]
Abstract
BACKGROUND In Canada, tissue distribution is managed by provincial entities. In 2014, Hema-Quebec established a cryopreserved vascular tissue bank accessible to all Canadian hospitals. The objectives of this report were to review the first 5 years of activity of Hema-Quebec's vascular bank and to briefly assess the competitiveness of its products. METHODS Deceased donors, ages 15 to 60, were screened for common blood-borne diseases. Grafts were treated in a triple-antibiotic solution at 35°C before preservation at -100°C. Hema-Quebec's vascular graft records were analyzed from 2014 to 2019 inclusively. RESULTS The average donor age was 35 years old and 78% of donors were men. Overall, 63% of harvested grafts cleared the quality management system. Positive microbial cultures and morphologic defects were the major reasons for graft discard. As such, a total of 60 grafts were delivered between 2016 and 2019 to 8 hospital centers. Moreover, the bank achieved a mean activity increase of 55% per year and Hema-Quebec's homografts were 48% less costly compared with similar homographs from for-profit organizations. CONCLUSIONS Our findings demonstrate that Hema-Quebec has established a viable cryopreserved vascular tissue bank with steady increase in activity and an acceptable graft discard rates and pricing. Based on our findings, we recommend that efforts should be directed to expand the tissue bank graft distribution outside the province of Quebec.
Collapse
Affiliation(s)
- Gabriel Georges
- Laval University, Cardiac Surgery Department, Institut Universitaire de Cardiologie et de Pneumologie de Québec (IUCPQ), Quebec City, Canada.
| | | | - Mazen Dakkak
- Héma-Québec, Côte-Vertu Ouest, Saint-Laurent, Canada
| | - Ghislain Nourissat
- Laval University, Vascular Surgery Department, Saint-François d'Assise Hospital, Quebec City, Canada
| | - Guillaume Febrer
- Hôpital du Sacré-Coeur de Montréal, Vascular Surgery Department, Montreal, Canada
| |
Collapse
|
5
|
Impact of valve fenestrations and structural changes in homografts on the long-term outcome in the recipient. Cell Tissue Bank 2021; 22:399-408. [PMID: 33576920 PMCID: PMC8426220 DOI: 10.1007/s10561-020-09886-5] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Journal Information] [Subscribe] [Scholar Register] [Received: 06/27/2020] [Accepted: 12/04/2020] [Indexed: 11/03/2022]
Abstract
Homografts have long been used for right ventricular outflow tract (RVOT) reconstruction. Tissue banks struggle to meet the clinical demand of tissue, with insufficient donor availability and strict recommendations on tissue quality with high proportions of discards. This study analyzes the long-term outcome of patients receiving a homograft with small fenestrations of the cusps or other structural changes, to evaluate if minor impairment of the homograft affects the durability. Homograft characteristics and patient outcome were described. Follow-up was maximum 24 years. Structural changes of the homografts were analyzed in relation to patient outcome, using univariable and multivariable Cox proportional hazard regression. Between 1995 and 2018, 468 patients received 535 homografts in the RVOT in Lund. Median recipient age was 13 years. There were 137 (26.9%) reinterventions. Freedom from reintervention was 75.8% (95% CI 71.3-79.7%) at 10 years and 57.4% (95% CI 50.0-64.0%) at 20 years. Small fenestrations of the cusps, fibrosis of the cusps and minor atheromatosis of the vessel did not show any statistically significant impact on long-term outcome, hazard ratio = 0.46 (95% CI 0.11-1.87, p = 0.276) and hazard ratio = 0.80 (95% CI 0.25-2.56, p = 0.704). Minor structural changes of the homografts seem to be acceptable without affecting the long-term durability.
Collapse
|
6
|
Transplantation of cryopreserved human heart valves in Europe: 30 years of banking in Brussels and future perspectives. Cell Tissue Bank 2021; 22:519-537. [PMID: 33532987 PMCID: PMC7853167 DOI: 10.1007/s10561-021-09902-2] [Citation(s) in RCA: 3] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 11/11/2020] [Accepted: 01/20/2021] [Indexed: 11/27/2022]
Abstract
For over 30 years, our TE has processed, controlled for quality and distributed cryopreserved allograft valves for human application. We present a review of this activity and future perspectives of cardiovascular tissue banking. The donor age and medical/behavioral history are in compliance with the regulations of the EUMS. Allograft morphology and function are evaluated in a class A cleanroom. Tests for viral/bacterial infection, histological control of structure/infection/malignancy and control-rate cryopreservation are performed. A total of 7562 hearts were sent to our TE, whereas 7290 valves (pulmonary, aortic and mitral) were transplanted. The donations increased over time: 1934, 2566 and 3062 hearts were donated during the first, second and third decades (increases of 32.7 and 19.3% during the second and third decades). Likewise, there was a significant increase in transplantations with 2050, 2550 and 2690 valves implanted during the first, second and third decades (24.4 and 5.5% increase during the second and third decades). A total of 4475 pulmonary (61.4%), 2760 aortic (37.9%) and 55 mitral valves (0.7%) were transplanted. Outstanding long-term results in adults and evidence of immune-related deterioration of allografts in neonates and infants were demonstrated. Decellularization was suggested as a solution. One hundred pulmonary and 180 aortic valves were sent for transplantation after decellularization for the ESPOIR and ARISE clinical trials and beyond. The donation and transplantation activity increased progressively. Although cryopreserved valves represent the best substitute for diseased valves, accelerated failure appears after implantation in neonates and infants. The implementation of new technologies, such as decellularization, as a standard procedure for treatment of allograft valves will offer further improvements in allograft quality and increase of durability.
Collapse
|
7
|
Burkert J, Kochová P, Tonar Z, Cimrman R, Blassová T, Jashari R, Fiala R, Špatenka J. The time has come to extend the expiration limit of cryopreserved allograft heart valves. Cell Tissue Bank 2020; 22:161-184. [PMID: 32583302 DOI: 10.1007/s10561-020-09843-2] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/30/2020] [Accepted: 06/13/2020] [Indexed: 12/12/2022]
Abstract
Despite the wide choice of commercial heart valve prostheses, cryopreserved semilunar allograft heart valves (C-AHV) are required, and successfully transplanted in selected groups of patients. The expiration limit (EL) criteria have not been defined yet. Most Tissue Establishments (TE) use the EL of 5 years. From physiological, functional, and surgical point of view, the morphology and mechanical properties of aortic and pulmonary roots represent basic features limiting the EL of C-AHV. The aim of this work was to review methods of AHV tissue structural analysis and mechanical testing from the perspective of suitability for EL validation studies. Microscopic structure analysis of great arterial wall and semilunar leaflets tissue should clearly demonstrate cells as well as the extracellular matrix components by highly reproducible and specific histological staining procedures. Quantitative morphometry using stereological grids has proved to be effective, as the exact statistics was feasible. From mechanical testing methods, tensile test was the most suitable. Young's moduli of elasticity, ultimate stress and strain were shown to represent most important AHV tissue mechanical characteristics, suitable for exact statistical analysis. C-AHV are prepared by many different protocols, so as each TE has to work out own EL for C-AHV.
Collapse
Affiliation(s)
- Jan Burkert
- Department of Transplantation and Tissue Banking, Czech National Allograft Heart Valve Bank, Department of Cardiovascular Surgery, Motol University Hospital, and Second Faculty of Medicine Charles University in Prague, V Úvalu 84, 150 06, Prague, Czech Republic
| | - Petra Kochová
- Department of Transplantation and Tissue Banking, Czech National Allograft Heart Valve Bank, Department of Cardiovascular Surgery, Motol University Hospital, and Second Faculty of Medicine Charles University in Prague, V Úvalu 84, 150 06, Prague, Czech Republic. .,NTIS - New Technologies for the Information Society, Faculty of Applied Sciences, University of West Bohemia, Technická 8, Pilsen, Czech Republic.
| | - Zbyněk Tonar
- NTIS - New Technologies for the Information Society, Faculty of Applied Sciences, University of West Bohemia, Technická 8, Pilsen, Czech Republic.,Department of Histology and Embryology, Biomedical Centre, Faculty of Medicine in Pilsen, Charles University in Prague, Karlovarská 48, 301 66, Pilsen, Czech Republic
| | - Robert Cimrman
- NTIS - New Technologies for the Information Society, Faculty of Applied Sciences, University of West Bohemia, Technická 8, Pilsen, Czech Republic
| | - Tereza Blassová
- Department of Histology and Embryology, Biomedical Centre, Faculty of Medicine in Pilsen, Charles University in Prague, Karlovarská 48, 301 66, Pilsen, Czech Republic
| | - Ramadan Jashari
- European Homograft Bank, Saint-Jean Clinic, Rue du Meridien 100, 1210, Brussels, Belgium
| | - Radovan Fiala
- Department of Transplantation and Tissue Banking, Czech National Allograft Heart Valve Bank, Department of Cardiovascular Surgery, Motol University Hospital, and Second Faculty of Medicine Charles University in Prague, V Úvalu 84, 150 06, Prague, Czech Republic
| | - Jaroslav Špatenka
- Department of Transplantation and Tissue Banking, Czech National Allograft Heart Valve Bank, Department of Cardiovascular Surgery, Motol University Hospital, and Second Faculty of Medicine Charles University in Prague, V Úvalu 84, 150 06, Prague, Czech Republic
| |
Collapse
|